Dr. Jack Kruse’s ideas on the mechanisms of Fluoroquinolone Toxicity. This is an above average read for many, but some great ideas can be gleaned from it.
The medical profession and its relation to fluoroquinolones and their use and knowledge of.
Every once in a while I get the dubious honor of talking to a doctor who has been floxed. This conversation was a poignant example of dangerous the FQ’s are in our society
One culprit that is often overlooked in chronic Fluoroquinolone toxicity is small intestinal bacterial overgrowth, or SIBO.
One hundred patients who went to the Emergency Room and received a Fluoroquinolone were studied, in ninety nine of those cases, errors were made with the Fluoroquinolone!
A interesting two part series covering our five year research relationship with Dr. Noble, U of R; In this article, part 2, he reveals troubling findings about Levaquin.
Dr. Miriam J. de Jonge M.D., who herself was floxed has contacted me and asked me to post, what I feel, is a comprehensive and well documented “Dear Colleague” letter, informing other doctors of (FQ) toxicity. It can be used to foster patient/doctor discussions. It is available here to download.
Dr. Linda Martin, Dr. Alan Redd, David Melvin, and John Fratti submitted an abstract for the UMDF Symposium on behalf of the FQ community. We are pleased to announce that, after being peer-reviewed by the UMDF Abstract Review Committee, their abstract was selected as a poster for the Symposium.
Charles Bennett MD PhD Chair of the Center for Economic Excellence in Medication Safety and Efficacy, Bennett-flashUniversity of South Carolina will be speaking at the PharmedOut’s 5th Annual Conference on June 11-12, 2015 at Georgetown University about Fluoroquinolones..
Our FQ team will be working closely with Dr. Golomb as she takes research to the next level in the near future. Stay tuned here as I will be sure to inform the FQ community of any pertinent developments with her, along with developments with other researchers that we work with.
A simple three step action that logically links FQ’s to the ability to initiate delayed adverse “late effect” reactions. There are no grand leaps of faith or conjecture required to link the steps.
Have you taken a fluoroquinolone antibiotic such as Cipro (ciprofloxacin), Levaquin (levofloxacin), or Avelox (moxifloxacin)? Would you be willing to help in a survey-based medical research study?